21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer

被引：0
|
作者：
Gulisa Turashvili
Joanne F. Chou
Edi Brogi
Monica Morrow
Maura Dickler
Larry Norton
Clifford Hudis
Hannah Y. Wen
机构：
[1] Memorial Sloan Kettering Cancer Center,Department of Pathology
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
[3] Memorial Sloan Kettering Cancer Center,Department of Surgery
[4] Memorial Sloan Kettering Cancer Center,Department of Medicine
来源：
Breast Cancer Research and Treatment | 2017年 / 166卷
关键词：
Breast cancer; 21-Gene recurrence score assay; Recurrence score; Locoregional recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：69 / 76
页数：7
相关论文
共 50 条
  • [1] 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Turashvili, Gulisa
    Chou, Joanne F.
    Brogi, Edi
    Morrow, Monica
    Dickler, Maura
    Norton, Larry
    Hudis, Clifford
    Wen, Hannah Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 69 - 76
  • [2] Predictive value of 21-gene recurrence score assay in non-estrogen receptor-positive and lymph node-negative breast cancer
    Lu, Kai
    Li, Hui
    Wu, Zhaoshu
    Liu, Dong
    Ye, Hongling
    Xu, Liang
    Liu, Yanwen
    JOURNAL OF BUON, 2018, 23 (05): : 1297 - 1301
  • [3] Clinical significance of 21-gene recurrence score assay for hormone receptor-positive, lymph node-negative breast cancer in early stage
    Yang Yu-qing
    Wang Lei
    Huang Mei-ling
    Xiao Jing-jing
    Wei Mei-chen
    Wu Jiang
    Hao Jun-sheng
    Ling Rui
    Li Nan-lin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 : 150 - 155
  • [4] Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer
    Minji Koh
    Jinhong Jung
    Su Ssan Kim
    Seung Do Ahn
    Eun Kyung Choi
    Il Yong Chung
    Jong Won Lee
    Sung-Bae Kim
    Jae Ho Jeong
    Breast Cancer Research and Treatment, 2021, 188 : 583 - 592
  • [5] Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer
    Koh, Minji
    Jung, Jinhong
    Kim, Su Ssan
    Do Ahn, Seung
    Choi, Eun Kyung
    Chung, Il Yong
    Lee, Jong Won
    Kim, Sung-Bae
    Jeong, Jae Ho
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (03) : 583 - 592
  • [6] Effect of 21-Gene Recurrence Score Results on Treatment Recommendations in Patients with Lymph Node-Positive, Estrogen Receptor-Positive Breast Cancer
    Oratz, R.
    Chao, C.
    Skrzypczak, S.
    Kim, B.
    Broder, M.
    CANCER RESEARCH, 2009, 69 (24) : 602S - 602S
  • [7] 21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer
    Kizy, Scott
    Altman, Ariella M.
    Marmor, Schelomo
    Denbo, Jason W.
    Jensen, Eric H.
    Tuttle, Todd M.
    Hui, Jane Yuet Ching
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (02) : 322 - 329
  • [8] Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer
    Jessica F. Partin
    Eleftherios P. Mamounas
    Annals of Surgical Oncology, 2011, 18 : 3399 - 3406
  • [9] Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer
    Partin, Jessica F.
    Mamounas, Eleftherios P.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (12) : 3399 - 3406
  • [10] Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
    Mamounas, Eleftherios P.
    Tang, Gong
    Fisher, Bernard
    Paik, Soonmyung
    Shak, Steven
    Costantino, Joseph P.
    Watson, Drew
    Geyer, Charles E., Jr.
    Wickerham, D. Lawrence
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : 1677 - 1683
12345